PMID: 9426106Jan 13, 1998Paper

New immunosuppressive regimens in lung transplantation

The European Respiratory Journal
N Briffa, R E Morris

Abstract

Survival after lung transplantation is less than 50% after 5 yrs and is limited by infection and obliterative bronchiolitis. There is, therefore, a need for new immunosuppressive regimens if we are to attempt to improve long-term survival. Several trials in lung transplantation of new immunosuppressive agents are in the planning stages. In this article, we review the experience with a new monoclonal agent (interleukin 2 (IL2) receptor antagonist) in kidney transplantation, together with the pharmacokinetic (PK) and pharmacodynamic properties and experience in transplantation in general, of the more promising of the new xenobiotic compounds (cyclosporine microemulsion, mycophenolate mofetil, tacrolimus and sirolimus). Recent novel approaches to the vexing problem of resistant lung rejection and obliterative bronchiolitis, such as the use of aerosolized cyclosporine, methotrexate, total lymphoid irradiation and phototherapy, are discussed. Finally an immunosuppressive regimen, using these new drugs in lung transplantation is suggested.

Citations

Mar 10, 2001·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·K KawaharaT Shirakusa
Apr 8, 2009·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Stephan KoromWalter Weder
Apr 11, 2001·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·L D SharplesJ Wallwork
May 2, 2002·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·P BorgerG H Koëter
Jan 18, 2003·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·J CairnM Yacoub
Jul 8, 1999·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·S W HirtH U Wottge
Jun 12, 2004·Dimensions of Critical Care Nursing : DCCN·Rosemary L Hoffmann, Tricia Roesch
Dec 12, 2001·Transplantation·D L DeMeo, L C Ginns
Jun 30, 2004·Transplantation·Katrin E HostettlerPeter Borger
Jun 25, 2005·American Journal of Respiratory and Critical Care Medicine·Bryan YatesPaul A Corris
Aug 21, 2009·Clinical Pharmacokinetics·Caroline Monchaud, Pierre Marquet
Aug 27, 2009·Clinical Pharmacokinetics·Caroline Monchaud, Pierre Marquet
Jul 17, 2014·La Presse médicale·David LaunayUNKNOWN Working Group on Heart/Lung transplantation in systemic sclerosis of the French Network on Pulmonary Hypertension
Mar 16, 2007·Expert Opinion on Emerging Drugs·Babith MankidyHarish Seethamraju
Jul 5, 2005·Expert Opinion on Investigational Drugs·M Behrend
Jun 30, 2009·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Muhammet R CelikSelim M Arcasoy
Jan 24, 2007·Thoracic Surgery Clinics·Errol L Bush, Shu S Lin
Feb 13, 2001·Annual Review of Medicine·D L DeMeo, L C Ginns
Dec 9, 2008·Current Opinion in Organ Transplantation·Peter M Hopkins, Keith McNeil
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·B Diane Reams, Scott M Palmer
Jul 19, 2002·Chest Surgery Clinics of North America·Alexander G Duarte, Scott Lick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.